Sun Pharma buys Taro Pharma shares from Brandes
Sun Pharmaceutical announced purchase of 3,712,557 shares, equivalent to an additional 9.4% stake in Taro Pharmaceutical Industries. These shares bought by Sun Pharma’s indirect subsidiary, Alkaloida Chemical Company Exclusive Group Ltd, from Brandes Investment Partners, L.P increases Sun Pharma and its subsidiaries stake in Taro Pharma to 34.4%.